Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen

Latest point in tit-for-tat battle between rivals

Lucid Group bolsters its senior client services team with two magical new hires

Lucid Group boosts its senior client services team with the arrival of David Pearce and Sandra Burke, both as client operational directors.With 15 years of Med Comms experience, David has...

Lucid Group Communications Limited

- PMLiVE

NHS leaders warn of no-deal Brexit flu vaccine delays

Follows prior delay in production of the vaccine

- PMLiVE

Novartis scores promising phase 3 MS study

Takes fight to Roche’s blockbuster ocrevus

AstraZeneca AZ

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

Will now decide whether to file treatment for approval

The Power of Teamwork #LucidLife

At our summer meeting we came together to experience the real power of #teamwork through drumming, learning to listen and react as one voice #MedEd #MedComms #CompanyMeeting #AfricanDrumming #LucidLife

Lucid Group Communications Limited

- PMLiVE

Strike three for Rova-T has AbbVie cutting its losses

Will funnel R&D money into more promising projects

- PMLiVE

Tecentriq approved in Europe for triple negative breast cancer

Roche can dominate in niche setting

- PMLiVE

‘Therapeutic overcrowding’ could hit big pharma returns

Jefferies analysts identify most at-risk companies

Apex launches Lumentium UK demo experience to pharma market

Something genuinely different has come to the UK events market.

Apex Events and Exhibitions

Three strategies for managing loss of exclusivity successfully

Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.

Blue Latitude Health

- PMLiVE

Celgene boosts IO presence with Immatics deal

Immatics technology promises to go beyond CAR-T capabilities

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links